The history of Induction is one of fast growth, fuelled by inventive solutions for the most common problems that clinicians and patients encounter in secondary care. At our creation in 2019, the immediate uptake of our products validated our promise to remove friction from the most basic but essential tasks.

 

Induction Switch, which allows hospital staff to share phone numbers and bleeps, bookmarks, documents and messages securely, climbed to 100,000 users in this time. Momentum only continued as Induction MicroGuide (now known as Induction Guidance) made it increasingly easier for hospital staff to share local guidance, distribute it widely – and best of all, adhere to it.

 

By early 2020, Switch and Guidance gained traction and embedded themselves into several NHS Trusts just in time to be mobilised in the fight against COVID-19. The solutions helped hospitals navigate through unknown territory and adjust to a quickly evolving, and often remote, work environment. Induction Switch was used as a primary communication tool at the NHS Nightingale London – the first of the temporary critical care hospitals constructed during the pandemic. MicroGuide was also selected to support Barts Health NHS Trust in the Nightingale London project with antimicrobial and COVID-19 content.

As the pandemic evolved, so too did our support of the NHS. Later in the year, as vaccines became available, Induction platforms helped frontline NHS staff book their own vaccinations and also facilitated delivery of lateral flow tests for COVID-19. Through all of this, Induction still found time in 2020 to expand its offering with the acquisition of Zesty, a market-leading patient portal that allows easy access to appointment bookings, clinical letters and copies of clinical records. Induction Zesty brings patients and data to Induction, transforming its potential for future offers.

 

2021 saw Royal Free London NHS Foundation Trust, a Global Digital Exemplar, use Induction Zesty as the foundation for its own patient portal. At the same time, Milton Keynes University Hospital NHS Trust maximised the number of patients accessing their health records with the platform. Partnerships with Apple inc. and Cerner have helped to create a direct, encrypted connection between medical institutions and patient’s iPhones, empowering patients – and powering efficiency and decision-making at a clinical level.

 

As new use cases and partnerships grow by the day, Induction has its eyes firmly fixed on the future of healthcare, ready to seize a multitude of opportunities that make life easier through the many stages of a patient journey.

Company Timeline

2021

January – Our Induction Zesty platform is working in collaboration with Apple Inc and health IT services group Cerner has recently supported the rollout of Health Records on iPhone to patients at the Milton Keynes University Hospital NHS Trust (MKUH), one of the first two NHS hospital trusts to launch the feature in the UK.

 

Apple Inc will be availing of Zesty’s  patient portal and high patient adoption rates as well as Cerner Millennium, an electronic health records platform, to maximise the number of patients accessing their health records on their iPhone.

 

Patient medical records are usually held in multiple locations, requiring them to log in to each care provider’s website to piece together the information manually. Health Records on iPhone creates a direct, encrypted connection between medical institutions and a patient’s iPhone, allowing them to see a central view of their allergies, conditions, immunisations, lab results, medications, procedures and vitals.

 

Induction Zesty sign a  contract with the Royal Free London NHS Foundation Trust (RFL) and delivered the My RFL Care patient portal as the first phase of an ambitious roadmap for RFL’s digital patient services for the next two years.

2020

April – In response to the COVID-19 pandemic in the UK, six critical care temporary hospitals were set up. The first of these hospitals to open was the NHS Nightingale Hospital London, where Induction Switch and MicroGuide, now Induction Guidance were selected as the collaboration and communication tools for the hospital which was preparing for potential capacity of up to 5,000 beds. Both products were used for secure communications, guideline access, and training for clinicians redeployed to the new hospital.

 

June – Acquisition of Zesty, a market-leading digital platform for patients visiting hospitals. The platform allows patients to book their appointments, read their appointment and clinical letters, store a local copy of their clinical record, and provide data to their care teams remotely. Alongside a compelling patient experience, the Zesty portal delivers significant cost benefits to hospitals. The completion of the Zesty Limited (“Zesty”) acquisition took place on 8th June 2020.

 

Zesty brings two important dimensions to the Induction Group: patients and data. Zesty has built a market-leading patient portal for hospitals in the UK and a powerful data integration platform, allowing third party applications to read and write data to the majority* of hospital electronic health record (EHR) systems. The Zesty acquisition was concluded almost entirely with shares, and has been transformational to the Group.

 

July – The Better Health Programme Mexico is part of the UK Global Prosperity Fund Better Health Programme that covers eight countries. The programme addresses the growing incidence of noncommunicable diseases in Mexico (especially in relation to obesity and diabetes) with the aim of enhancing the economic and social benefits associated with improved health. MicroGuide was chosen as part of the overall support approach in Mexico to distribute highly effective, up-to-date and impactful guidance to Mexican clinicians over the 3-year programme.The MicroGuide team are helping to create, streamline and focus guidance on a wide range of subjects. The short-term aim is for Mexican health specialists to use MicroGuide’s powerful content management system in order to update, maintain and publish guidance directly for themselves. This exciting deployment for MicroGuide in Mexico is further vindication that the service for providing the governance and distribution of clinical guidance has world-wide potential and impact.

 

August – Launch of My RFL Care portal for Royal Free London, which had and significant traction; with 50,000 patients both registering and using the service in the first few months. 250,000 patients are expected to adopt the service in the first year.

2019

May – The Group acquired the assets of Podmedics (including, Induction Switch, all intellectual property in relation to the Induction Switch app and the related user database) and were officially listed on the London Stock Exchange.

 

July – Induction Switch reached 100,000 registered users on the platform, making it the most used app by Clinicians in the UK.

 

November – Horizon (since acquired by Induction Healthcare in 2019) took this concept and built it into what is now the is the UK market leading service for digital clinical guidance.Induction Guidance (formally known as MicroGuide) was first conceived by Dr’s Sanjay Gupta and Kieran Hand in 2011 as a way to provide mobile access to antimicrobial guidance to local clinicians. With thousands of local content editors and hundreds of thousands of clinical content consumers, over 10 million MicroGuide content pages will be accessed this year alone. Presently, Induction Guidance has been implemented in 18 countries with the platform live in close to 90% of all Acute NHS Trusts and 140 medical organisations.

2018

The Group entered into negotiations to acquire Induction Switch, a UK-focused hospital phone directory from Podmedics Limited.

See how Induction can help

Book a Demo